Medication info
Youngil Sitagliptin Tablet 50 Milligrams (Sitagliptin Hydrochloride Monohydrate)

Youngil Sitagliptin Tablet 50 Milligrams (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Pale yellowish-pink round film-coated tablet with both sides convex
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202005308 · Approved 2020.07.23 · Insurance code 649405560

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function before starting this medicine and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood glucose control for patients with type 2 diabetes
View approved original text

This medication is used to assist in blood glucose control for patients with type 2 diabetes. It can be administered alone or in combination with dietary and exercise therapy, and may be used in combination with metformin if initial therapy is insufficient. Additionally, this medication may be added if blood glucose control is difficult even with other diabetes treatments such as sulfonylureas, metformin, thiazolidinediones, or insulin, alone or in combination. This improves blood glucose management through various treatment options.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function before starting this medicine and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication may cause allergic reactions; if symptoms such as skin rash, difficulty breathing, swelling of the face or neck occur, discontinue use immediately and consult a doctor. This medication may cause serious inflammation of the pancreas called pancreatitis; if symptoms such as abdominal pain, nausea, vomiting, or fever occur while taking this medication, visit a hospital immediately. Do not use this medication in patients with type 1 diabetes or diabetic ketoacidosis, and do not administer it to individuals with a known allergy to this medication or its components. Patients with impaired kidney function should have their dosage adjusted and undergo periodic kidney function tests before and during therapy. Hypoglycemic symptoms may occur while taking this medication, so blood glucose levels should be checked frequently, and caution is needed if taken together with other hypoglycemic agents such as insulin or sulfonylureas, as this may increase the risk of hypoglycemia. This medication may cause side effects such as upper respiratory infection, nasopharyngitis, headache, indigestion, diarrhea, and dizziness. Symptoms that are severe or persistent should be discussed with a doctor. It is advisable for pregnant or breastfeeding women not to take this medication, and safety and efficacy have not been established in children or adolescents under 18 years of age. Elderly patients may have a risk of reduced kidney function, so dosage adjustment and kidney function tests are needed. In cases of overdose, measures to remove the drug from the gastrointestinal tract should be taken, and the condition should be monitored through tests such as an electrocardiogram; hemodialysis may be performed if necessary. This medication generally has low interaction with other drugs; however, it is advisable to consult with a doctor or pharmacist when taken with specific medications. If unusual symptoms such as severe joint pain or blistering of the skin occur during treatment, inform a physician immediately, and discontinue use if necessary.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 27 more
  • nausea
  • constipation
  • vomiting
  • rash
  • urticaria
  • cutaneous vasculitis
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • acute renal failure
  • elevated liver enzymes
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • severe hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, at a temperature between 1 degrees to 30 degrees Celsius for optimal effect. This helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

Pale yellowish-pink round film-coated tablet with both sides convex

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.